December 23, 2008 - Amgen has submitted a Biologics License Application (BLA) with the FDA for denosumab, an investigational RANK Ligand inhibitor, as Amgen seeks FDA approval for treatment and prevention of postmenopausal osteoporosis (PMO) in women, and treatment and prevention of bone loss in patients undergoing hormone ablation for either prostate or breast cancer.

December 23, 2008 - The Moscow Municipal University of Psychology and Education in Moscow, Russia, and the University of Trento in Trento, Italy, have ordered Elekta Neuromag, equipment for noninvasive measurement of brain activity using magnetoencephalography (MEG) technology, for research purposes.

December 23, 2008 — The Alfred in Melbourne, Australia, used AngioDynamics’s NanoKnife system, which leverages irreversible electroporation (IRE) technology, on a lymph node metastasis and the first lung lesion case.

December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement to acquire Axsun Technologies Inc., a privately-held company that is a developer and manufacturer of lasers and optical engines used in medical optical coherence tomography (OCT) imaging systems and advan

December 22, 2008 – Siemens Healthcare made significant contributions to the U.S. communities where it operates, pledging over $740,000 this holiday season as part of its annual giving campaign for organizations and charities throughout the U.S. through volunteer opportunities, employee contributions and matching company donations.

December 22, 2008 - SenoRx Inc. said the United States Patent and Trademark Office has granted the company its sixth brachytherapy-related patent and fourth patent directly related to its Contura Multi-Lumen Radiation Balloon (MLB) catheter for the treatment of breast cancer.

December 22, 2008 - The Medipattern Corp. and iPACS.US LLC have signed a non-exclusive original equipment manufacturing (OEM) agreement allowing iPACS to integrate B-CAD into its product line, according to Medipattern.

December 19, 2008 — While radiation treatments deliver precise doses of high-energy X-rays to stop cancer cells from spreading or to shrink tumors, oncologists have become increasingly concerned about inadvertent exposures during head and neck cancer treatments to nerves responsible for upper body mobility.